$CMPS 4 SEC Filings

Filed On	Filing
05 Aug 2026	Form 4: Nath Kabir, Director Gave up 5,962 shares to cover exercise price or tax ($67.1K)
29 May 2026	Form 4: Karydas Daphne, Director Granted 21,110 Share Option (Right to Buy)
29 May 2026	Form 4: Santini Gino, Director Granted 30,158 Share Option (Right to Buy)
29 May 2026	Form 4: Gover Justin D., Director Granted 21,110 Share Option (Right to Buy)
29 May 2026	Form 4: Jonas Jeffrey M, Director Granted 21,110 Share Option (Right to Buy)
29 May 2026	Form 4: Riley Wayne Joseph, Director Granted 21,110 Share Option (Right to Buy)
29 May 2026	Form 4: McQuade Robert, Director Granted 21,110 Share Option (Right to Buy)
29 May 2026	Form 4: Norton David Y, Director Granted 21,110 Share Option (Right to Buy)
29 May 2026	Form 4: Tregoning Kathleen, Director Granted 41,119 Share Option (Right to Buy)
27 Mar 2026	Form 4: Nath Kabir, Director Received 175,000 shares as a grant or award · Granted 367,815 Share Option (Right to Buy)
27 Mar 2026	Form 4: Goodwin Guy, Chief Medical Officer Granted 170,600 Share Option (Right to Buy)
27 Mar 2026	Form 4: Loxam Teri, Chief Financial Officer Received 75,000 shares as a grant or award · Granted 157,635 Share Option (Right to Buy)
13 Mar 2026	Form 4: Nath Kabir, Director Gave up 13,131 shares to cover exercise price or tax ($90.5K)
13 Mar 2026	Form 4: Loxam Teri, Chief Financial Officer Gave up 1,781 shares to cover exercise price or tax ($12.3K)
03 Mar 2026	Form 4: Loxam Teri, Chief Financial Officer Gave up 4,467 shares to cover exercise price or tax ($31.4K)
03 Feb 2026	Form 4: Nath Kabir, Director Gave up 16,181 shares to cover exercise price or tax ($107K)
31 Oct 2025	Form 4: Jonas Jeffrey M, Director Granted 52,000 Share Option (Right to Buy)
04 Aug 2025	Form 4: Nath Kabir, Director Gave up 6,366 shares to cover exercise price or tax ($27.6K)
30 Jul 2025	Form 4: Gover Justin D., Director Granted 52,000 Share Option (Right to Buy)
13 Jun 2025	Form 4: Santini Gino, Director Granted 39,000 Share Option (Right to Buy)

Comments